Merck Lipfendra Approval: FDA Clears Breakthrough Pill as Stock Drops -1.75%
Will the revolutionary Merck Lipfendra Approval be enough to offset the looming $32 billion Keytruda patent cliff for investors?
Will the revolutionary Merck Lipfendra Approval be enough to offset the looming $32 billion Keytruda patent cliff for investors?